©The Author(s) 2024.
世界华人消化杂志. 2024-06-28; 32(6): 405-411
在线出版 2024-06-28. doi: 10.11569/wcjd.v32.i6.405
在线出版 2024-06-28. doi: 10.11569/wcjd.v32.i6.405
表2 SNHG16在消化系统肿瘤中的临床病理特征
| 肿瘤类型 | 临床特征 | 参考文献 |
| GC | Invasion depth, lymph node metastasis, TNM stage, histological differentiation | [7] |
| GC | Tumor size, TNM stage, poor survival | [8] |
| GC | Invasion depth | [11] |
| CRC | TNM stage | [13] |
| CRC | Metastasis, lymph node | [14] |
| CRC | LV1, PNI, TNM stage, lymph node, metastasis, distant metastasis, poor prognosis | [19] |
| ESCC | Tumor stage, lymph nodes metastasis, clinical stage, poor survival, poor prognosis | [21] |
| ESCC | Tumour differentiation, T stage | [24] |
| PC | Poor prognosis | [26] |
| PC | Gemcitabine resistance | [28] |
| HCC | Tumor size, AFP level, PVTT, metastasis, poor survival, sorafenib resistance | [31] |
| HCC | Multiple tumors, macrovascular invasion, poor prognosis | [32] |
| HCC | Serum AFP level, poor prognosis | [33] |
| HCC | Tumor size, TNM stage, ALT level, HBV DNA level | [34] |
| HCC | Tumor size, lymph node status, TNM stage and poor prognosis | [36] |
| HCC | Poor prognosis | [37] |
| HCC | Tumour diameter, tumour thrombus, tumour satellites, poor prognosis | [38] |
| HCC | Sorafenib resistance | [39] |
| HCC | Tumor size, TNM stage, vascular invasion, sorafenib resistance | [40] |
| HCC | Poor prognosis | [44] |
引文著录: 叶惠, 李明月, 施瑞华. 长链非编码RNA SNHG16在消化系统肿瘤中作用机制研究进展. 世界华人消化杂志 2024; 32(6): 405-411